Clinical Trial NCT04469465
Trial
Alexion – ALXN2040-PNH-301 ALPHA
Clinical trial ID
NCT04469465
Drug name
ALXN2040 D2a8n)icopan
Company:
Alexion
Drug trade name
Voydeya®
Phase of study
3
Current status
Active, not recruiting
Start
12/2020
Substance
Low molecular compound
Research question
Add-on therapy to eculizumab or ravulizumab, ALXN2040vs placebo
Delivery method of drug
Oral
Frequency
3 x daily
Clinical trial locations
Brazil Canada Czechia France Germany Greece Israel Italy Japan Malaysia Netherlands Poland South Korea Spain Taiwan Thailand UK USA